Clinical Trial Update: Blood Viscosity, End-Stage Renal Disease, And Mortality (BEAM-1)

View source ↗

Summary

BEAM-1 is a clinical trial evaluating the impact of blood viscosity on outcomes in patients undergoing renal replacement therapy, including end-stage renal dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: ProMetrics, Inc. | Conditions: Renal Replacement Therapy | Status: UNKNOWN